Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the observational study is to ascertain the degree of blood pressure control in the early-morning hours after 8 weeks of treatment with Telmisartan/Telmisartan+Hydrochlorothiazide and during 44 weeks of follow-up, in patients with hypertension using home blood pressure measurements.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan

Criteria

Inclusion Criteria:

• Patients with mild to moderate essential hypertension and whose medical condition make them eligible for treatment with Telmisartan/Telmisartan+HCTZ

Exclusion Criteria:

• Pre-menopausal women who had had no birth control, who are pregnant or nursing

• Patients with advanced hepatic impairment, advanced renal impairment or both

• Patients with functional class III or IV (NYHA) congestive heart failure (CHF), unstable angina, acute myocardial infarction, heart surgery or stroke within the previous six months

• Patients with any valvular disease with hemodynamic repercussion

• Patients receiving chronic administration of oral anticoagulants or digoxin

• Patients with known hypersensitivity to any component in the formulation of Micardis / MicardisPlus

• Patients with previous history of angioedema associated with ACE inhibitors

• Patients with severe, uncontrolled hypertension or any form of secondary hypertension

• Patients with any other clinical conditions which, in the opinion of the investigator, would not allow for the safe completion of the protocol